Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
7.09
-0.24 (-3.27%)
At close: Dec 5, 2025, 4:00 PM EST
7.15
+0.06 (0.85%)
After-hours: Dec 5, 2025, 7:58 PM EST
Myriad Genetics Market Cap
Myriad Genetics has a market cap or net worth of $660.89 million as of December 5, 2025. Its market cap has decreased by -51.60% in one year.
Market Cap
660.89M
Enterprise Value
727.79M
1-Year Change
-51.60%
Ranking
Category
Stock Price
$7.09
Market Cap Chart
Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $660.89M, an increase of 546.03%. That is a compound annual growth rate of 7.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 660.90M | -47.05% |
| Dec 31, 2024 | 1.25B | -20.67% |
| Dec 29, 2023 | 1.57B | 33.81% |
| Dec 30, 2022 | 1.18B | -46.65% |
| Dec 31, 2021 | 2.20B | 48.19% |
| Dec 31, 2020 | 1.49B | -26.57% |
| Dec 31, 2019 | 2.03B | -6.80% |
| Dec 31, 2018 | 2.17B | -8.61% |
| Dec 29, 2017 | 2.38B | 108.51% |
| Dec 30, 2016 | 1.14B | -62.13% |
| Dec 31, 2015 | 3.01B | 21.14% |
| Dec 31, 2014 | 2.49B | 58.51% |
| Dec 31, 2013 | 1.57B | -29.30% |
| Dec 31, 2012 | 2.22B | 25.03% |
| Dec 30, 2011 | 1.77B | -15.91% |
| Dec 31, 2010 | 2.11B | -15.93% |
| Dec 31, 2009 | 2.51B | -18.54% |
| Dec 31, 2008 | 3.08B | 50.95% |
| Dec 31, 2007 | 2.04B | 64.00% |
| Dec 29, 2006 | 1.24B | 93.29% |
| Dec 30, 2005 | 643.90M | -6.71% |
| Dec 31, 2004 | 690.20M | 98.11% |
| Dec 31, 2003 | 348.40M | -0.17% |
| Dec 31, 2002 | 349.00M | -71.84% |
| Dec 31, 2001 | 1.24B | -34.15% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |